Introduction

Cryptogenic stroke (CS) is defined as cerebral ischemia of obscure origin. The cause of CS remains undetermined because the event is transitory or reversible, investigations did not look for all possible causes, or because some causes truly remain unknown. CS is more frequent in younger than older patients and it was found that when it is properly investigated, the most frequent causes would be cardiac embolism, followed by vasculopathy, and coagulopathy [1]. Strokes may remain cryptogenic if diagnostic evaluation is incomplete for one or another reason or in the presence of multiple competitive causes, such as atrial fibrillation (AF) and atherosclerotic stenosis in an ipsilateral relevant artery [2].

A PFO is a flap-like valve that connects the right and left atria. It is instrumental in the fetal circulation by allowing oxygenated blood to bypass the immature lungs and pass directly into the left atrium. A PFO typically closes after birth but may remain open in up to 25% of adults, creating a shunt between the right and left atria. A meta-analysis of case-control studies showed the prevalence of PFO is higher in cryptogenic stroke, specifically in patients younger than 55 years [3]. A proposed mechanism of ischemic stroke in the setting of an atrial septal abnormality like PFO is paradoxical embolism from a distal source (deep vein thrombosis in the lower extremity or pelvis, or thrombi from the atrial septal defect or transient atrial arrhythmias). The embolus then migrates directly into the arterial vasculature through a cardiac atrial or ventricular septal defect, essentially bypassing the pulmonary circulation [4].

TCD is an alternative method for indirectly diagnosing PFO by assessing the presence of a RLS. It employs the functional assessment of the shunt using insonation of middle cerebral artery MCA during a venous injection of agitated saline and Valsalva maneuver. After contrast injection, bubbles enter the systemic circulation during this transient RLS, resulting in microembolic signals in the cerebral arteries that are detected by TCD. TCD utilizes a pulsed Doppler transducer that detects the velocity and intensity of cerebral arterial blood flow by spectral analysis. The trade-off between TCD and TEE for detection of RLS is still a matter of controversy. TCD might be valuable for prediction of recurrent stroke or transient ischemic attack in patients with PFO [5].

Aim of the work

To detect sensitivity and specificity of contrast-enhanced TCCD in detection of right to left shunting among stroke patients with PFO in comparison to TEE.

Methods

It is a cross-sectional study conducted during the period from July 2016 till August 2018. The sample consisted of 482 ischemic stroke patients admitted to the stroke unit during the period from July 2016 to August 2018 of which 55 patients were classified to be of undetermined etiology according to (TOAST) classification [6]. NIIHSS and MRS were done for all patients on admission and after 1 month.

Inclusion criteria and patient selection

  • Age: more than 18 years. Clinical presentation of cerebrovascular stroke (defined as the presence of rapidly developing focal neurological signs or symptoms of vascular origin that persists for more than 1 h) [7]. Routine diagnostic tools [routine lab, carotid ultrasound, trans-thoracic echocardiography (TTE), electrocardiogram (ECG)] were normal to categorize patient as cryptogenic stroke as minimum required diagnostic tools mentioned in American Heart and Stroke Associations [8].

  • Cryptogenic stroke patients were excluded from enrollment if one of the following criteria was met:

  • Age less than 18 years or more than 60 years

  • Medically unstable patients or have contraindications to used investigations

  • Patients who rejected enrollment in the study

Methods

Written informed consent was obtained from the patients participating in the study, or their first-degree relatives if the patient was unable to provide consent due to weakness or disturbed conscious level, after informing them about the study rationale and their right to withdraw from the study at any time without any consequences. All patients were subjected to history taking including personal data, past history, history of vascular risk factors, detailed history of current illness.

General and neurological examination

Laboratory investigations

ESR, CRP, ANA, Anti DNA, anticardiolipin antibody, lupus anticoagulant, ANCA P and ANCA C, Protein C, protein S, and antithrombin ш were done for all patients to exclude autoimmune etiologies and hypercoagulopathies. CT brain to exclude intracerebral hemorrhage. MRI brain (Philips 1.5 Tesla) (diffusion weighted, Flair, T1, T2, and T2* images) and MRA. Transesophageal echocardiography (GE Healthcare, vivid E9 with 6 DT-D TEE probe) was done for detection of PFO and RLS. Agitated saline was injected and monitored to detect right to left shunting (without and then with Valsalva maneuver). TEE was also used to detect other findings: atrial septal aneurysm (ASA), intracardiac thrombi, and aortic atheromatous plaques. Forty-eight hours Holter ECG (Norav Holter NH-301). Contrast-enhanced transcranial color-coded duplex (esaote mylab 5, Italy using 2-4 MHZ phased array probe) was done for patients for detection of microembolic signals in the middle cerebral artery for confirmation of the presence of patent foramen ovale and presence of right to left shunting by using agitated saline consisted of 1 ml of air vigorously mixed with 8.5 ml of saline solution and injected into the antecubital vein via a three-way stopcock immediately after contrast preparation. If no microbubbles were detected after the first injection, then a further two injections were made with a Valsalva maneuver. Microembolic signals were considered positive if detected within 30 s from contrast injection and grading was considered grade 1 (microemboli 1-10), grade (microemboli 11-30), and grade 3 (microemboli 31-100) [9].

Statistical analysis

Statistical analysis was conducted using SPSS V24 (SPSS, IBM, Chicago, IL, USA). P values were considered significant if < 0.05. Descriptive statistics were used for patient demographics, chi-squared test was used to compare normally distributed demographics, likelihood ratio was used to compare abnormally distributed variables. T test was used to compare means of NIH and mRs on admission and at 3 months, as well as age distribution. Kaplan-Meier survival curves were plotted to display the relation of time to Holter, and arrhythmia discovery.

Results

Demographic data of CS patients

Our study group consisted of 55 patients with cryptogenic cerebrovascular stroke included 34 males (61.8%) and 21 females (38.2%), and their ages ranged from 26 to 59 years with mean age of 39.11 ± 8.319 years.

Transesophageal echocardiography findings

TEE findings showed that 9 patients had interatrial septal aneurysm (ASA) (16.7%), 16 patients had patent foramen ovale (PFO) (29.6%) of which 10 patients showed positive shunting by TEE (using agitated saline, Valsalva maneuver, and abdominal compression); of them, 13 patients had RoPE score of 6 points or more, 4 patients had intracardiac thrombi (7.4%), 5 patients had descending aorta plaques (9.3%) only one of them had complex aortic plaque (which is defined as increased echo density and thickening of the intima > 5 mm with shaggy overlying echogenic material and marked irregularities in the intimal wall), and 2 patients had filamentous mass in relation to the aortic valve (3.7%) (Table 1).

Table 1 Abnormal findings in transesophageal echo (sources of cardioembolism)

Holter ECG

On performing 48 h Holter ECG for our 55 cryptogenic stroke patients some patients as early as 4 days and with maximum of 42 days, two short runs of paroxysmal AF (pAF) were detected in 2 patients (3.7%), both patients had their Holter done during the first 10 days from stroke onset.

Contrast-enhanced transcranial duplex

TCD was done for 55 CS patients for assessment of right to left shunting by detection of microembolic signals in MCA, 6 patients tested positive for shunting (17.1%). All microembolic signals were less than 10 microemboli (grade 1).

On testing characteristics of TCD in detecting RLS compared to the gold standard of TEE, TCD sensitivity was 85.7%, specificity was 100%, negative predictive value was 96.55%, and positive predictive value was 100% (Table 2).

Table 2 Association between right to left shunting through trans-esophageal echo and trans-cranial duplex

Discussion

The embolic appearance of most cryptogenic strokes implies that the cause is embolism from an occult source in the heart, aorta, or large artery. Cardioaortic conditions with a low or uncertain risk for embolic stroke include difficult to diagnose occult AF and related atrial cardiopathies, atrial septal abnormalities, complex aortic atheroma, and others.

In our study, TEE and contrast-enhanced TCD were done to compare RLS detection and results showed that TCD sensitivity was 85.7%, specificity was 100%, negative predictive value was 96.55%, and positive predictive value was 100% denoting that TCD is a very good alternative tool for RLS detection as it is considered less invasive and has very good sensitivity compared to TEE and that was consistent with a study conducted in 2014 by Mojadidi and co-workers [10] who conducted a systematic review to assess intracardiac RLS detection using TCD compared with TEE and concluded that the weighted mean sensitivity and specificity for TCD were 97% and 93%, respectively which is considered close to our study results.

In 2016, Joshua and co-workers [5] studied the frequency of detection of a RLS using TEE and TCD among patients with CS and concluded that TCD might be more sensitive than TEE for detection of RLS, which misses some cases with substantial RLS, and might be valuable for prediction of recurrent stroke or transient ischemic attack in patients with PFO. TCD complements TEE for management of suspected paradoxical embolism and this is quite consistent with our study results. In our study, TEE revealed that 16 patients had PFO comprising 29.6% of patients, 9 patients had ASA comprising 16% of patients, of these patients 6 of them had both PFO and ASA comprising 10.9% of our study group, 4 patients had intra-cardiac thrombi comprising 7.4% of patients, and 5 patients had descending aortic plaques comprising 9.3% of patients noting that PFO and ASA prevalence in the general population is 25% and 2.42% respectively.

Regarding PFO percentage in our study, it was quite different from the results of the study done in 2009 by Alsheikh and co-workers [11] who found that PFO prevalence is up to 40% in patients with CS, suggesting that it may be conduit for stroke caused by paradoxical embolism rather than just an incidental finding which is considered higher percentage than that found in our study.

Yet our results were consistent with the study done in 2017 by Schneider and co-workers [12] who conducted a study on CS patients and concluded that the prevalence of PFO was higher in CS patients’ group 30.9% compared to other stroke subtypes 21.9%. At the end of this study, we explored that contrast-enhanced TCD is considered a useful tool with high sensitivity for detection of right to left shunting yet TEE is needed to differentiate different causes of shunting.

Study limitations

The study sample still small to prove the high sensitivity of TCD in detection of right to left shunting.

Conclusion

We concluded that PFO is considered an important hidden etiology for ischemic stroke. Contrast-enhanced TCD is considered a sensitive method for detection of right to left shunting among PFO patients.